China’s first oral anti-COVID-19 drug Azvudine will be covered by China s national medical insurance system after negotiations, China s National Healthcare Security Administration said Sunday evening.
The study by researchers from healthcare provider Clalit, Ben-Gurion University of the Negev and Sapir College has not yet been peer reviewed. Factbox-Countries mandate COVID tests for China travellers Authorities around the world are imposing or considering curbs on travellers from China as COVID-19 cases there surged following its relaxation of "zero-COVID" rules.